+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Targeting Peptides Market - Global Forecast 2025-2030- Product Image
Cardiac Targeting Peptides Market - Global Forecast 2025-2030- Product Image
Sale

Cardiac Targeting Peptides Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125846
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cardiac targeting peptides are transforming cardiovascular medicine by providing unmatched specificity in diagnostics, drug delivery, and therapeutic intervention. This report delivers clear, structured intelligence for senior leaders looking to unlock innovation, navigate regulatory change, and achieve strong positioning in this rapidly evolving sector.

Market Snapshot: Cardiac Targeting Peptides Landscape

The cardiac targeting peptides market is experiencing dynamic growth, propelled by a rising prevalence of cardiovascular diseases and mounting demand for precision therapies. Advancements in peptide sequence design, conjugation chemistries, and digital health integration have broadened applications across diagnostics and therapeutics, fostering new standards in targeted intervention and patient care. As regulatory frameworks adapt and regional partnerships deepen, organizations are facing a shifting environment with evolving supply chains and increased investment in scalable, resilient manufacturing strategies.

Scope & Segmentation

This report offers an in-depth analysis covering every critical segment and emerging technology shaping the global market. The comprehensive segmentation framework includes:

  • Product Types: Diagnostics peptides, dual function peptides, and therapeutic peptides — including biomarker detection agents, imaging agents, angiogenic, anti-apoptotic, and cardioprotective varieties.
  • Applications: Diagnostic imaging (MRI, PET, ultrasound), targeted drug delivery (hydrogel-based, liposomal, and nanoparticle systems), and therapeutic treatment (arrhythmia, heart failure, infarction management).
  • End Users: Hospitals, cardiac specialty clinics, tertiary care centers, pharmaceutical and biotech companies, and diverse research institutes including CROs, universities, and government labs.
  • Delivery Systems: Liposomal conjugates (conventional, stealth), nanoparticle carriers (gold, lipid, polymer), and polymer conjugates (PEG, PLGA-based systems).
  • Molecule Types: Cyclic peptides, dendrimer-based peptides, and linear peptides defined by chain length and structural attributes.
  • Regional Coverage: Americas (including the United States, Canada, and key Latin American markets), Europe, Middle East & Africa, and Asia-Pacific (China, India, Japan, and others).

Key technologies defining the field include dual function peptide constructs for combined imaging and therapy, AI-powered peptide optimization tools, advanced hydrogels, and modular manufacturing platforms.

Key Takeaways for Senior Decision-Makers

  • Precision medicine advances are catalyzing the development of cardiac targeting peptides that enable both diagnostic imaging and targeted therapy within a single intervention.
  • Innovations in conjugation techniques now allow peptides to deliver therapeutic payloads while providing real-time clinical feedback, supporting more personalized treatment approaches.
  • AI-driven algorithms are streamlining peptide candidate identification, optimizing receptor interactions, and refining delivery system design, shortening development cycles.
  • Regional disparities in regulatory pathways, patient access, and intellectual property protection are driving organizations to formulate tailored go-to-market and clinical adoption strategies.
  • Collaborative networks involving pharmaceutical companies, biotech firms, and academic spin-outs are expanding preclinical innovation and accelerating scalability from research to commercialization.
  • Dual function and targeted peptides are shifting reimbursement models and clinical workflows, emphasizing the need for robust real-world evidence and patient stratification in adoption planning.

Tariff Impact: United States Policy and Global Supply Chains

Recent U.S. tariff measures have raised costs for imported peptide materials, prompting organizations to re-examine sourcing and production approaches. Companies increasingly pivot toward local synthesis, strategic regional partnerships, and shared R&D models to offset fiscal pressures. These shifts are also fostering joint investment in domestic manufacturing capacity and encouraging decentralized supply networks, enabling sustained progress in peptide pipeline advancement despite trade headwinds.

Methodology & Data Sources

Analysis integrates expert insights from cardiology professionals, peptide chemists, regulatory authorities, and pharma executives. Secondary research includes peer-reviewed literature, patent filings, clinical trial data, industry white papers, scientific conferences, and validated company disclosures. Findings are cross-verified and subject to rigorous bias and quality checks, with careful segmentation to ensure a multidimensional view.

Primary Keyword: Cardiac Targeting Peptides

Why This Report Matters

  • Actionable guidance on aligning pipeline innovation with commercial feasibility in a highly segmented and regulated market.
  • Clear visibility into technological breakthroughs, competitive dynamics, and strategic risks driven by shifting trade policies and global supply chain changes.
  • Enables senior decision-makers to prioritize investments, build resilient regional partnerships, and accelerate time-to-market for targeted peptide solutions.

Conclusion

Cardiac targeting peptides are redefining the boundaries of cardiovascular intervention and diagnostics. By leveraging data-driven insight, strategic collaboration, and adaptive market entry, organizations can capitalize on new opportunities and navigate sector challenges with confidence.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of novel peptide-mediated delivery systems for targeted myocardial therapeutics
5.2. Integration of imaging-compatible cardiac homing peptides in diagnostic and theranostic applications
5.3. Advancements in peptide design for enhanced receptor specificity in ischemic heart tissue targeting
5.4. Regulatory approvals influencing clinical translation of cardiac-targeting peptide therapeutics
5.5. Partnerships between biotech firms and academic institutions for novel cardiac peptide discovery
5.6. Use of peptide-induced targeted gene delivery approaches for heart failure therapy
5.7. Growth of personalized medicine leveraging patient-specific cardiac homing peptides for treatment
5.8. Investment trends accelerating commercialization of next-generation myocardial targeting peptides
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Targeting Peptides Market, by Product Type
8.1. Introduction
8.2. Diagnostics Peptides
8.2.1. Biomarker Detection Agents
8.2.1.1. Biosensor Probes
8.2.1.2. Elisa Probes
8.2.2. Imaging Agents
8.2.2.1. Mri Contrast Peptides
8.2.2.2. Pet Tracers
8.3. Dual Function Peptides
8.3.1. Drug Delivery Imaging Peptides
8.3.2. Imaging Therapy Peptides
8.4. Therapeutic Peptides
8.4.1. Angiogenic Peptides
8.4.1.1. Fgf Mimetic Peptides
8.4.1.2. Vegf Mimetic Peptides
8.4.2. Anti Apoptotic Peptides
8.4.2.1. Bcl2 Modulating Peptides
8.4.2.2. Caspase Inhibitor Peptides
8.4.3. Cardioprotective Peptides
8.4.3.1. Ischemia Reperfusion Injury Peptides
8.4.3.2. Myocardial Infarction Peptides
9. Cardiac Targeting Peptides Market, by Application
9.1. Introduction
9.2. Diagnostic Imaging
9.2.1. Mri Imaging
9.2.1.1. Gadolinium Conjugated Peptides
9.2.1.2. Iron Oxide Conjugated Peptides
9.2.2. PET Imaging
9.2.2.1. Fluorine 18 Labeled Peptides
9.2.2.2. Gallium 68 Labeled Peptides
9.2.3. Ultrasound Imaging
9.2.3.1. Microbubble Targeted Peptides
9.3. Targeted Drug Delivery
9.3.1. Hydrogel Based Delivery
9.3.1.1. Injectable Hydrogels
9.3.1.2. Thermoresponsive Hydrogels
9.3.2. Liposomal Delivery
9.3.2.1. PEGylated Liposomes
9.3.2.2. PH Sensitive Liposomes
9.3.3. Nanoparticle Delivery
9.3.3.1. Gold Nanoparticles
9.3.3.1.1. Rod Shaped Gold Nanoparticles
9.3.3.1.2. Spherical Gold Nanoparticles
9.3.3.2. Iron Oxide Nanoparticles
9.4. Therapeutic Treatment
9.4.1. Arrhythmia Control
9.4.1.1. Antiarrhythmic Peptides
9.4.2. Heart Failure Treatment
9.4.2.1. Hfpef Treatment Peptides
9.4.2.2. Hfref Treatment Peptides
9.4.3. Myocardial Infarction Management
9.4.3.1. Acute Mi Peptides
9.4.3.2. Chronic Mi Repair Peptides
10. Cardiac Targeting Peptides Market, by End User
10.1. Introduction
10.2. Hospitals and Clinics
10.2.1. Cardiac Specialty Clinics
10.2.1.1. Outpatient Clinics
10.2.1.2. Surgical Centers
10.2.2. Tertiary Care Hospitals
10.2.2.1. Private Hospitals
10.2.2.2. Public Hospitals
10.3. Pharmaceutical Companies
10.3.1. Big Pharma
10.3.1.1. Top 10 Pharma
10.3.2. Biotech Firms
10.3.2.1. Mid Size Biotechs
10.3.2.2. Small Biotechs
10.4. Research Institutes
10.4.1. Academic Institutions
10.4.1.1. Government Labs
10.4.1.2. Universities
10.4.2. CROs
10.4.2.1. Clinical CROs
10.4.2.2. Preclinical CROs
11. Cardiac Targeting Peptides Market, by Delivery System
11.1. Introduction
11.2. Liposomal Conjugates
11.2.1. Conventional Liposomes
11.2.1.1. Cationic Liposomes
11.2.1.2. Neutral Liposomes
11.2.2. Stealth Liposomes
11.2.2.1. Mannose Modified Liposomes
11.2.2.2. PEGylated Liposomes
11.3. Nanoparticle Conjugates
11.3.1. Gold Nanoparticles
11.3.1.1. Rod Shaped Gold Nanoparticles
11.3.1.2. Spherical Gold Nanoparticles
11.3.2. Lipid Nanoparticles
11.3.2.1. Nanoemulsions
11.3.2.2. Solid Lipid Nanoparticles
11.3.3. Polymer Nanoparticles
11.3.3.1. Chitosan Nanoparticles
11.3.3.2. PLGA Nanoparticles
11.4. Polymer Conjugates
11.4.1. PEG Conjugates
11.4.1.1. Branched PEG Conjugates
11.4.1.2. Linear PEG Conjugates
11.4.2. PLGA Conjugates
11.4.2.1. Microparticles
11.4.2.2. Nanoparticles
12. Cardiac Targeting Peptides Market, by Molecule Type
12.1. Introduction
12.2. Cyclic Peptides
12.2.1. Disulfide Cyclized
12.2.1.1. Mono Disulfide
12.2.1.2. Multi Disulfide
12.2.2. Head to Tail Cyclized
12.2.2.1. Backbone Cyclized
12.2.2.2. Side Chain Cyclized
12.3. Dendrimer Based Peptides
12.3.1. PAMAM Dendrimers
12.3.1.1. Generation 4
12.3.1.2. Generation 5
12.3.2. PPI Dendrimers
12.3.2.1. Generation 3
12.3.2.2. Generation 4
12.4. Linear Peptides
12.4.1. Long Chain Peptides
12.4.1.1. 21 to 50 Amino Acids
12.4.1.2. >50 Amino Acids
12.4.2. Short Chain Peptides
12.4.2.1. 10 to 20 Amino Acids
12.4.2.2. < 10 Amino Acids
13. Americas Cardiac Targeting Peptides Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiac Targeting Peptides Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiac Targeting Peptides Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk a/S
16.3.2. Ferring Pharmaceuticals Inc.
16.3.3. Merck KGaA
16.3.4. Pfizer Inc.
16.3.5. Amgen Inc.
16.3.6. Novartis AG
16.3.7. Sanofi S.A.
16.3.8. AstraZeneca PLC
16.3.9. Eli Lilly and Company
16.3.10. Bristol-Myers Squibb Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIAC TARGETING PEPTIDES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC TARGETING PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CARDIAC TARGETING PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CARDIAC TARGETING PEPTIDES MARKET: RESEARCHAI
FIGURE 26. CARDIAC TARGETING PEPTIDES MARKET: RESEARCHSTATISTICS
FIGURE 27. CARDIAC TARGETING PEPTIDES MARKET: RESEARCHCONTACTS
FIGURE 28. CARDIAC TARGETING PEPTIDES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIAC TARGETING PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER DETECTION AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER DETECTION AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOSENSOR PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOSENSOR PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ELISA PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ELISA PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER DETECTION AGENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOMARKER DETECTION AGENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI CONTRAST PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI CONTRAST PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET TRACERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET TRACERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING AGENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING AGENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS PEPTIDES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTICS PEPTIDES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DUAL FUNCTION PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DUAL FUNCTION PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DRUG DELIVERY IMAGING PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DRUG DELIVERY IMAGING PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING THERAPY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IMAGING THERAPY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DUAL FUNCTION PEPTIDES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DUAL FUNCTION PEPTIDES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANGIOGENIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANGIOGENIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY FGF MIMETIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY FGF MIMETIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY VEGF MIMETIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY VEGF MIMETIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANGIOGENIC PEPTIDES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANGIOGENIC PEPTIDES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTI APOPTOTIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTI APOPTOTIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BCL2 MODULATING PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BCL2 MODULATING PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CASPASE INHIBITOR PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CASPASE INHIBITOR PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTI APOPTOTIC PEPTIDES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTI APOPTOTIC PEPTIDES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIOPROTECTIVE PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIOPROTECTIVE PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ISCHEMIA REPERFUSION INJURY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ISCHEMIA REPERFUSION INJURY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIOPROTECTIVE PEPTIDES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIOPROTECTIVE PEPTIDES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC PEPTIDES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GADOLINIUM CONJUGATED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GADOLINIUM CONJUGATED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IRON OXIDE CONJUGATED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IRON OXIDE CONJUGATED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI IMAGING, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MRI IMAGING, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY FLUORINE 18 LABELED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY FLUORINE 18 LABELED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GALLIUM 68 LABELED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GALLIUM 68 LABELED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET IMAGING, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PET IMAGING, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MICROBUBBLE TARGETED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MICROBUBBLE TARGETED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HYDROGEL BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HYDROGEL BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY INJECTABLE HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY INJECTABLE HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERMORESPONSIVE HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERMORESPONSIVE HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HYDROGEL BASED DELIVERY, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HYDROGEL BASED DELIVERY, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEGYLATED LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEGYLATED LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PH SENSITIVE LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PH SENSITIVE LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL DELIVERY, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL DELIVERY, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ROD SHAPED GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ROD SHAPED GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SPHERICAL GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SPHERICAL GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IRON OXIDE NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY IRON OXIDE NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TARGETED DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ARRHYTHMIA CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ARRHYTHMIA CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTIARRHYTHMIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ANTIARRHYTHMIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ARRHYTHMIA CONTROL, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ARRHYTHMIA CONTROL, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HEART FAILURE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HEART FAILURE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HFPEF TREATMENT PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HFPEF TREATMENT PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HFREF TREATMENT PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HFREF TREATMENT PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HEART FAILURE TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HEART FAILURE TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACUTE MI PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACUTE MI PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CHRONIC MI REPAIR PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CHRONIC MI REPAIR PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MYOCARDIAL INFARCTION MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TERTIARY CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TERTIARY CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TOP 10 PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY TOP 10 PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIG PHARMA, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIG PHARMA, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MID SIZE BIOTECHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MID SIZE BIOTECHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SMALL BIOTECHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SMALL BIOTECHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOTECH FIRMS, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BIOTECH FIRMS, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 195. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 196. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 197. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 198. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 199. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 200. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 201. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 202. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 203. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 204. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 205. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 206. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 207. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 208. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CLINICAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 209. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 210. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 211. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 212. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 213. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 214. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 215. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 216. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 217. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 218. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 219. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CONVENTIONAL LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 220. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CONVENTIONAL LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 221. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CATIONIC LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 222. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CATIONIC LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 223. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NEUTRAL LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 224. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NEUTRAL LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 225. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CONVENTIONAL LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 226. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CONVENTIONAL LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 227. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STEALTH LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 228. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STEALTH LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 229. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MANNOSE MODIFIED LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 230. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MANNOSE MODIFIED LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 231. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEGYLATED LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 232. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEGYLATED LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 233. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STEALTH LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 234. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY STEALTH LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 235. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL CONJUGATES, 2018-2024 (USD MILLION)
TABLE 236. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPOSOMAL CONJUGATES, 2025-2030 (USD MILLION)
TABLE 237. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 238. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 239. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 240. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 241. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ROD SHAPED GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 242. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY ROD SHAPED GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 243. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SPHERICAL GOLD NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 244. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SPHERICAL GOLD NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 245. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 246. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY GOLD NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 247. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 248. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 249. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOEMULSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 250. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOEMULSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 251. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 252. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 253. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPID NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 254. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LIPID NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 255. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 256. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 257. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CHITOSAN NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 258. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CHITOSAN NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 259. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 260. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 261. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 262. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 263. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE CONJUGATES, 2018-2024 (USD MILLION)
TABLE 264. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLE CONJUGATES, 2025-2030 (USD MILLION)
TABLE 265. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 266. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 267. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 268. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 269. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BRANCHED PEG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 270. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY BRANCHED PEG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 271. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LINEAR PEG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 272. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY LINEAR PEG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 273. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEG CONJUGATES, 2018-2024 (USD MILLION)
TABLE 274. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PEG CONJUGATES, 2025-2030 (USD MILLION)
TABLE 275. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 276. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 277. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MICROPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 278. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MICROPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 279. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 280. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 281. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA CONJUGATES, 2018-2024 (USD MILLION)
TABLE 282. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY PLGA CONJUGATES, 2025-2030 (USD MILLION)
TABLE 283. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER CONJUGATES, 2018-2024 (USD MILLION)
TABLE 284. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY POLYMER CONJUGATES, 2025-2030 (USD MILLION)
TABLE 285. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 286. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 287. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 288. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 289. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DISULFIDE CYCLIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 290. GLOBAL CARDIAC TARGETING PEPTIDES MARKET SIZE, BY DISULFIDE CYCLIZED, BY REGION, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiac Targeting Peptides market report include:
  • Novo Nordisk A/S
  • Ferring Pharmaceuticals Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Amgen Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company

Related Reports

Radiopharmaceuticals for Diagnosis Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceuticals for Diagnosis Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
PNA Conjugates Market - Global Forecast 2025-2030 - Product Image

PNA Conjugates Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Insights 2025 - Product Image

MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Insights 2025

  • Report
  • 80 Pages
  • Global
From
Peptides and Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Peptides and Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033 - Product Image

Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.